Patents Assigned to Sigma-Tau
  • Patent number: 6245800
    Abstract: A pharmaceutical composition is described, comprising a lipid-lowering drug such as lovastatin, simvastatin, pravastatin and fluvastatin and L-carnitine or an alkanoyl L-carnitine, which, while conserving the efficacy of the lipid-lowering drug, is substantially devoid of the toxic or side effects typical of such drugs.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: June 12, 2001
    Assignee: Sigma-Tau
    Inventors: Arduino Arduini, Alessandro Peschechera, Paolo Carminati
  • Patent number: 5962525
    Abstract: 6,7-disubstituted-2-aminotetralines of general formula (1) ##STR1## and their pharmacologically acceptable salts, wherein X and Y, identical or different are selected from the group consisting of methoxy, acetoxy and fluoro; and R and R.sub.1, identical or different, are selected from the group consisting of hydrogen, ethyl, propyl, cyclopropylmethyl, 2-hydroxy-2-phenylethyl, 2-hydroxy-2-(4-methylphenyl)ethyl and 2-hydroxy-3-(4-methoxyphenoxy)propyl are endowed with immunomodulator activity.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: October 5, 1999
    Assignee: Sigma-Tau
    Inventors: Piero Foresta, Mauro Marzi, Maria Ornella Tinti
  • Patent number: 4401827
    Abstract: Novel acyl-derivatives of the .beta.-hydroxy-.gamma.-butyrobetaine are disclosed (typically pyruvyl carnitine hydrochloride) which are useful therapeutic agents in the treatment of cardiac disorders, hyperlipidoemias and hyperlipoproteinemias.
    Type: Grant
    Filed: December 28, 1981
    Date of Patent: August 30, 1983
    Assignee: Sigma-Tau
    Inventor: Paolo de Witt
  • Patent number: 4100289
    Abstract: A novel cysteine thiolactone of nicotinamide is disclosed having the formula: ##STR1## The compounds, homo-cysteine thiolactone of nicotinamide, and its pharmacologically acceptable salts have the useful pharmacological activity of lowering cholesterol, free fatty acid and triglyceride plasma level in the case of altered lipid metabolism and improving BSP clearance ratio in cases of liver injury.A synthesis of the compound from nicotinoyl chloride, hydrochloride or nicotinic acid esters is described as well as modes for the administration of the compound.
    Type: Grant
    Filed: December 27, 1976
    Date of Patent: July 11, 1978
    Assignee: Sigma-Tau
    Inventor: Claudio Cavazza
  • Patent number: 3968872
    Abstract: A dispenser and dispenser closure for storing two products separately in and on a necked container for eventual mixing thereof and dispensing them as a mixture. A sealed cup-shaped plug closes the container and has a bottom that is punchable or pierceable. The container contains a first material that is to be mixed with a second material contained in the cup-shaped plug externally of the container interior. A dispensing element which is a tubular punching piston is disposed slidable axially in the cup and is provided with a leading edge at an inner open end for punching or piercing the plug's bottom for introducing the second material into the container upon being depressed. The punching piston fixed therein coaxially therewith a dispensing tube open at both ends. A removable cover closes an outer end of the tube and removed therefrom automatically upon the punching piston being displaced.
    Type: Grant
    Filed: August 2, 1974
    Date of Patent: July 13, 1976
    Assignee: Sigma-Tau
    Inventor: Claudio Cavazza